City

Canton (1)

Condition

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Taiho Oncology, Inc. (1)

Collaborator

Intervention

tas6417 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

advanced or metastatic nscls with exon 20 insertion mutation

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation Trial in Canton (TAS6417)

Recruiting

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation

TAS6417

Canton, Ohio

Gabrail Cancer and Research Center

Jul 25, 2023